A Study of Selexipag in Participants Who Participated in a Previous Selexipag Study
Status:
Recruiting
Trial end date:
2028-09-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the long-term safety of selexipag while providing
continued selexipag treatment for participants who were previously enrolled in an
Actelion-sponsored study with selexipag and who derived benefit from selexipag in indications
for which a positive benefit-risk has been established.